GT Biopharma, Inc. (the "Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
If a recent update from journalist Mark Hendry in his Substack column (as posted in X) is believed to be true, Celtic are ...
North Korean authorities have launched another so-called mopping-up operation—a sweeping crackdown—on users of Chinese mobile ...
Celtic make enquiry over West Ham striker Callum Wilson; the Hoops are trying to gauge his interest in joining them this ...
The public catering management office in Kaechon, South Pyongan province, has begun replacing many vendors at soft drink ...
The Croatian striker’s mentor Senijad Ibricic believes the world is his oyster as top five league future is mapped out ...
Iran's collapse or survival hinges on one choice inside the Revolutionary Guard Archaeologists thought they found wires ...
GT Biopharma submitted an IND application for GTB-5550 TriKE for solid tumors. Phase 1 trial planned for 2026.
Chelsea and David Datro Fofana are working on a permanent exit this window, with Celtic, Royal Antwerp and Derby County all ...
President Lee Jae Myung and Japanese Prime Minister Sanae Takaichi on Tuesday emphasized the importance of South Korea–Japan ...
Kovacevic isn't the only striker being targeted by Celtic in January, with Fabrizio Romano also reporting that the club have ...